Core Scientific, Inc.
CORZ
$19.57
-$0.22-1.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 780.44% | 589.61% | 150.23% | -13.05% | -46.63% |
| Total Other Revenue | -65.50% | -55.19% | -47.23% | -15.70% | -43.63% |
| Total Revenue | 108.83% | 44.92% | -15.97% | -14.95% | -44.28% |
| Cost of Revenue | 27.93% | 19.39% | -45.43% | -19.17% | -28.04% |
| Gross Profit | 1,293.91% | 266.57% | 115.51% | 2,603.21% | -87.05% |
| SG&A Expenses | 9.06% | 37.36% | -9.62% | 58.24% | 44.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 131.44% | -38.64% | 1,631.30% | -5,418.93% | -5,202.23% |
| Total Operating Expenses | 71.64% | 19.14% | 15.20% | -4.39% | -33.64% |
| Operating Income | 207.88% | 38.84% | -118.47% | -20.33% | -252.74% |
| Income Before Tax | -23.14% | -160.12% | 155.21% | 67.80% | -16.39% |
| Income Tax Expenses | 1,106.96% | 192.68% | -74.67% | -6.72% | 9.72% |
| Earnings from Continuing Operations | -23.33% | -160.25% | 155.14% | 67.79% | -16.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.33% | -160.25% | 155.14% | 67.79% | -16.39% |
| EBIT | 207.88% | 38.84% | -118.47% | -20.33% | -252.74% |
| EBITDA | 222.98% | 68.13% | -1,754.40% | -171.70% | -77.17% |
| EPS Basic | -7,868.82% | -474.80% | 158.76% | 60.57% | 99.08% |
| Normalized Basic EPS | -12.49% | -109.51% | 201.66% | 75.11% | 35.87% |
| EPS Diluted | -7,868.82% | -474.80% | 140.47% | 60.57% | 99.08% |
| Normalized Diluted EPS | -12.49% | -109.51% | 169.92% | 75.11% | 35.87% |
| Average Basic Shares Outstanding | 2.31% | 2.45% | 4.40% | 8.92% | 78.14% |
| Average Diluted Shares Outstanding | 2.31% | 2.45% | 51.75% | 8.92% | 78.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |